MAPK/ERK signaling pathway in rheumatoid arthritis: mechanisms and therapeutic potential
PeerJ · 14.07.2025 · 13 · e19708
DOI: 10.7717/peerj.19708 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PeerJ, online erschienen am 14.07.2025. Verfasst von Jun Xie und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resource, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Chin…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, MAP Kinase Signaling System, Extracellular Signal-Regulated MAP Kinases. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology of China through the National Key R&D Plan, Sichuan Province Science and Technology Support Program.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a multifaced autoimmune disorder characterized by chronic joint inflammation, leading to progressive disability and significantly impacting patients’ quality of life. Despite advances in treatment, finding a cure or preventing disease progression remains a major clinical challenge, underscoring the urgent need for novel therapeutic strategies. Among various pathways involved in the pathophysiology of RA, the mitogen-activated protein kinases/extracellular regulated protein kinases (MAPK/ERK) pathway is of particular importance. As the central cascade within the broader MAPK signaling pathways, MAPK/ERK plays a critical role in regulating numerous physiological and pathological processes, with a well-established and prominent involvement in RA. Unlike p38 MAPK and c-Jun-N-terminal kinase (JNK), whose role in RA have been well-documented, the specific contributions of the MAPK/ERK pathway to RA remains comprehensively unreviewed. Furthermore, the MAPK/ERK pathway does not act in isolation but interacts synergistically with other major pathways, including NF-κB, Janus kinase-signal transducer and activator of transcription (JAK/STAT), sonic hedgehog (SHH), and PI3K/AKT, which further enhance its pathological effects. This review offers a comprehensive analysis of MAPK/ERK signaling pathway, focusing on its molecular components and its contribution to RA pathophysiology. Furthermore, we explore the cross-talk between MAPK/ERK and other pathways in the context of RA, and evaluates the therapeutic potential of targeting this pathway with small molecule inhibitors, natural compounds and biomolecules. By elucidating the mechanistic role of MAPK/ERK in RA, this article aims to highlight the pathway’s therapeutic relevance and provide a foundation for the developing more effective, targeted therapies for RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Southwestern Chinese Medicine Resource, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Santai People's Hospital, Mianyang, China.
- School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Förderung
- National Natural Science Foundation of China
- Ministry of Science and Technology of China through the National Key R&D Plan
- Sichuan Province Science and Technology Support Program
- Sichuan Provincial Administration of Traditional Chinese Medicine
- Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
Zitieren
APA
Xie, J., Sun, S., Li, Q., Chen, Y., Huang, L., Wang, D., & Wang, Y. (2025). MAPK/ERK signaling pathway in rheumatoid arthritis: mechanisms and therapeutic potential. PeerJ, 13, e19708. https://doi.org/10.7717/peerj.19708
Vancouver
Xie J, Sun S, Li Q, Chen Y, Huang L, Wang D, et al. MAPK/ERK signaling pathway in rheumatoid arthritis: mechanisms and therapeutic potential. PeerJ. 2025;13:e19708. doi:10.7717/peerj.19708
BibTeX
@article{Xie2025,
author = {Xie, Jun and Sun, Sijuan and Li, Qingzhou and Chen, Yuhui and Huang, Lijun and Wang, Dong and Wang, Yumei},
title = {MAPK/ERK signaling pathway in rheumatoid arthritis: mechanisms and therapeutic potential},
journal = {PeerJ},
year = {2025},
volume = {13},
pages = {e19708},
doi = {10.7717/peerj.19708}
}
EUVIMED